Review



metastat col-3  (MetaStat Inc)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    MetaStat Inc metastat col-3
    The cancer invasion and metastasis and its targeted therapy. The tumor metastasis process consists of multiple steps. Initially, tumor cells invade the surrounding stroma and extracellular matrix from the primary tumor site, and then intravasate into the bloodstream or the lymphatics. Subsequently, tumor cells arrest in the circulation and arrive at distant organ sites, followed by extravasating and invading the parenchyma of distant tissues. Finally, tumor cells adapt to the new microenvironment and grow to form metastatic colonization. EMT is the basic embryonic developmental process that transforms polarized non-motile epithelial cells into motile and invasive mesenchymal cells. Multiple cellular stress conditions including hypoxia, inflammation, metabolic stress, and signaling cascades, can induce the expression of EMT transcription factors and prompt tumor metastasis. Meanwhile, MET amplification and mutation, the transcriptional dysregulation of c-MET, degradation deficiency, and abnormal HGF production result in the abnormal expression of HGF/c-MET and tumor progression. Various <t>inhibitors</t> including MMP inhibitors and HGF/c-MET inhibitors have been developed and emerging as promising tools in the suppression of tumor metastasis. c-MET mesenchymal-epithelial transition factor, EMT epithelial-mesenchymal transition, HGF hepatocyte growth factor, <t>MMPs</t> matrix metalloproteinases
    Metastat Col 3, supplied by MetaStat Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/metastat col-3/product/MetaStat Inc
    Average 90 stars, based on 1 article reviews
    metastat col-3 - by Bioz Stars, 2026-03
    90/100 stars

    Images

    1) Product Images from "Tumor biomarkers for diagnosis, prognosis and targeted therapy"

    Article Title: Tumor biomarkers for diagnosis, prognosis and targeted therapy

    Journal: Signal Transduction and Targeted Therapy

    doi: 10.1038/s41392-024-01823-2

    The cancer invasion and metastasis and its targeted therapy. The tumor metastasis process consists of multiple steps. Initially, tumor cells invade the surrounding stroma and extracellular matrix from the primary tumor site, and then intravasate into the bloodstream or the lymphatics. Subsequently, tumor cells arrest in the circulation and arrive at distant organ sites, followed by extravasating and invading the parenchyma of distant tissues. Finally, tumor cells adapt to the new microenvironment and grow to form metastatic colonization. EMT is the basic embryonic developmental process that transforms polarized non-motile epithelial cells into motile and invasive mesenchymal cells. Multiple cellular stress conditions including hypoxia, inflammation, metabolic stress, and signaling cascades, can induce the expression of EMT transcription factors and prompt tumor metastasis. Meanwhile, MET amplification and mutation, the transcriptional dysregulation of c-MET, degradation deficiency, and abnormal HGF production result in the abnormal expression of HGF/c-MET and tumor progression. Various inhibitors including MMP inhibitors and HGF/c-MET inhibitors have been developed and emerging as promising tools in the suppression of tumor metastasis. c-MET mesenchymal-epithelial transition factor, EMT epithelial-mesenchymal transition, HGF hepatocyte growth factor, MMPs matrix metalloproteinases
    Figure Legend Snippet: The cancer invasion and metastasis and its targeted therapy. The tumor metastasis process consists of multiple steps. Initially, tumor cells invade the surrounding stroma and extracellular matrix from the primary tumor site, and then intravasate into the bloodstream or the lymphatics. Subsequently, tumor cells arrest in the circulation and arrive at distant organ sites, followed by extravasating and invading the parenchyma of distant tissues. Finally, tumor cells adapt to the new microenvironment and grow to form metastatic colonization. EMT is the basic embryonic developmental process that transforms polarized non-motile epithelial cells into motile and invasive mesenchymal cells. Multiple cellular stress conditions including hypoxia, inflammation, metabolic stress, and signaling cascades, can induce the expression of EMT transcription factors and prompt tumor metastasis. Meanwhile, MET amplification and mutation, the transcriptional dysregulation of c-MET, degradation deficiency, and abnormal HGF production result in the abnormal expression of HGF/c-MET and tumor progression. Various inhibitors including MMP inhibitors and HGF/c-MET inhibitors have been developed and emerging as promising tools in the suppression of tumor metastasis. c-MET mesenchymal-epithelial transition factor, EMT epithelial-mesenchymal transition, HGF hepatocyte growth factor, MMPs matrix metalloproteinases

    Techniques Used: Expressing, Amplification, Mutagenesis

    The typical and clinically developed MMPs inhibitors in cancer therapy
    Figure Legend Snippet: The typical and clinically developed MMPs inhibitors in cancer therapy

    Techniques Used:



    Similar Products

    metastat col-3  (MetaStat Inc)
    90
    MetaStat Inc metastat col-3
    The cancer invasion and metastasis and its targeted therapy. The tumor metastasis process consists of multiple steps. Initially, tumor cells invade the surrounding stroma and extracellular matrix from the primary tumor site, and then intravasate into the bloodstream or the lymphatics. Subsequently, tumor cells arrest in the circulation and arrive at distant organ sites, followed by extravasating and invading the parenchyma of distant tissues. Finally, tumor cells adapt to the new microenvironment and grow to form metastatic colonization. EMT is the basic embryonic developmental process that transforms polarized non-motile epithelial cells into motile and invasive mesenchymal cells. Multiple cellular stress conditions including hypoxia, inflammation, metabolic stress, and signaling cascades, can induce the expression of EMT transcription factors and prompt tumor metastasis. Meanwhile, MET amplification and mutation, the transcriptional dysregulation of c-MET, degradation deficiency, and abnormal HGF production result in the abnormal expression of HGF/c-MET and tumor progression. Various <t>inhibitors</t> including MMP inhibitors and HGF/c-MET inhibitors have been developed and emerging as promising tools in the suppression of tumor metastasis. c-MET mesenchymal-epithelial transition factor, EMT epithelial-mesenchymal transition, HGF hepatocyte growth factor, <t>MMPs</t> matrix metalloproteinases
    Metastat Col 3, supplied by MetaStat Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/metastat col-3/product/MetaStat Inc
    Average 90 stars, based on 1 article reviews
    metastat col-3 - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    metastat(col-3)  (MetaStat Inc)
    90
    MetaStat Inc metastat(col-3)
    The cancer invasion and metastasis and its targeted therapy. The tumor metastasis process consists of multiple steps. Initially, tumor cells invade the surrounding stroma and extracellular matrix from the primary tumor site, and then intravasate into the bloodstream or the lymphatics. Subsequently, tumor cells arrest in the circulation and arrive at distant organ sites, followed by extravasating and invading the parenchyma of distant tissues. Finally, tumor cells adapt to the new microenvironment and grow to form metastatic colonization. EMT is the basic embryonic developmental process that transforms polarized non-motile epithelial cells into motile and invasive mesenchymal cells. Multiple cellular stress conditions including hypoxia, inflammation, metabolic stress, and signaling cascades, can induce the expression of EMT transcription factors and prompt tumor metastasis. Meanwhile, MET amplification and mutation, the transcriptional dysregulation of c-MET, degradation deficiency, and abnormal HGF production result in the abnormal expression of HGF/c-MET and tumor progression. Various <t>inhibitors</t> including MMP inhibitors and HGF/c-MET inhibitors have been developed and emerging as promising tools in the suppression of tumor metastasis. c-MET mesenchymal-epithelial transition factor, EMT epithelial-mesenchymal transition, HGF hepatocyte growth factor, <t>MMPs</t> matrix metalloproteinases
    Metastat(Col 3), supplied by MetaStat Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/metastat(col-3)/product/MetaStat Inc
    Average 90 stars, based on 1 article reviews
    metastat(col-3) - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    chemical modified tetracyclines metastat (col-3)  (MetaStat Inc)
    90
    MetaStat Inc chemical modified tetracyclines metastat (col-3)
    Different Types of MMPIs Used in Cancer Treatment.
    Chemical Modified Tetracyclines Metastat (Col 3), supplied by MetaStat Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/chemical modified tetracyclines metastat (col-3)/product/MetaStat Inc
    Average 90 stars, based on 1 article reviews
    chemical modified tetracyclines metastat (col-3) - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    col-3 (metastat)  (MetaStat Inc)
    90
    MetaStat Inc col-3 (metastat)
    Different Types of MMPIs Used in Cancer Treatment.
    Col 3 (Metastat), supplied by MetaStat Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/col-3 (metastat)/product/MetaStat Inc
    Average 90 stars, based on 1 article reviews
    col-3 (metastat) - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    metastat/col-3  (MetaStat Inc)
    90
    MetaStat Inc metastat/col-3
    Different Types of MMPIs Used in Cancer Treatment.
    Metastat/Col 3, supplied by MetaStat Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/metastat/col-3/product/MetaStat Inc
    Average 90 stars, based on 1 article reviews
    metastat/col-3 - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    The cancer invasion and metastasis and its targeted therapy. The tumor metastasis process consists of multiple steps. Initially, tumor cells invade the surrounding stroma and extracellular matrix from the primary tumor site, and then intravasate into the bloodstream or the lymphatics. Subsequently, tumor cells arrest in the circulation and arrive at distant organ sites, followed by extravasating and invading the parenchyma of distant tissues. Finally, tumor cells adapt to the new microenvironment and grow to form metastatic colonization. EMT is the basic embryonic developmental process that transforms polarized non-motile epithelial cells into motile and invasive mesenchymal cells. Multiple cellular stress conditions including hypoxia, inflammation, metabolic stress, and signaling cascades, can induce the expression of EMT transcription factors and prompt tumor metastasis. Meanwhile, MET amplification and mutation, the transcriptional dysregulation of c-MET, degradation deficiency, and abnormal HGF production result in the abnormal expression of HGF/c-MET and tumor progression. Various inhibitors including MMP inhibitors and HGF/c-MET inhibitors have been developed and emerging as promising tools in the suppression of tumor metastasis. c-MET mesenchymal-epithelial transition factor, EMT epithelial-mesenchymal transition, HGF hepatocyte growth factor, MMPs matrix metalloproteinases

    Journal: Signal Transduction and Targeted Therapy

    Article Title: Tumor biomarkers for diagnosis, prognosis and targeted therapy

    doi: 10.1038/s41392-024-01823-2

    Figure Lengend Snippet: The cancer invasion and metastasis and its targeted therapy. The tumor metastasis process consists of multiple steps. Initially, tumor cells invade the surrounding stroma and extracellular matrix from the primary tumor site, and then intravasate into the bloodstream or the lymphatics. Subsequently, tumor cells arrest in the circulation and arrive at distant organ sites, followed by extravasating and invading the parenchyma of distant tissues. Finally, tumor cells adapt to the new microenvironment and grow to form metastatic colonization. EMT is the basic embryonic developmental process that transforms polarized non-motile epithelial cells into motile and invasive mesenchymal cells. Multiple cellular stress conditions including hypoxia, inflammation, metabolic stress, and signaling cascades, can induce the expression of EMT transcription factors and prompt tumor metastasis. Meanwhile, MET amplification and mutation, the transcriptional dysregulation of c-MET, degradation deficiency, and abnormal HGF production result in the abnormal expression of HGF/c-MET and tumor progression. Various inhibitors including MMP inhibitors and HGF/c-MET inhibitors have been developed and emerging as promising tools in the suppression of tumor metastasis. c-MET mesenchymal-epithelial transition factor, EMT epithelial-mesenchymal transition, HGF hepatocyte growth factor, MMPs matrix metalloproteinases

    Article Snippet: Other MMPs inhibitors such as COL-3 (NSC-683551), neovastat (AE-941), prinomastat (AG3340), BMS-275291, and metastat(COL-3), have been evaluated in clinical trials (Table ).

    Techniques: Expressing, Amplification, Mutagenesis

    The typical and clinically developed MMPs inhibitors in cancer therapy

    Journal: Signal Transduction and Targeted Therapy

    Article Title: Tumor biomarkers for diagnosis, prognosis and targeted therapy

    doi: 10.1038/s41392-024-01823-2

    Figure Lengend Snippet: The typical and clinically developed MMPs inhibitors in cancer therapy

    Article Snippet: Other MMPs inhibitors such as COL-3 (NSC-683551), neovastat (AE-941), prinomastat (AG3340), BMS-275291, and metastat(COL-3), have been evaluated in clinical trials (Table ).

    Techniques:

    Different Types of MMPIs Used in Cancer Treatment.

    Journal: International Journal of Molecular Sciences

    Article Title: Hypoxic Effects on Matrix Metalloproteinases’ Expression in the Tumor Microenvironment and Therapeutic Perspectives

    doi: 10.3390/ijms242316887

    Figure Lengend Snippet: Different Types of MMPIs Used in Cancer Treatment.

    Article Snippet: Chemical modified tetracyclines , Metastat (COL-3) , MMP-1, MMP-2, MMP-8, MMP-9, MMP-13 , [ , , , , ] .

    Techniques: Modification, Bioprocessing